Volume 36, Issue 10, Page 18 (October 2008)
17 of 61
PREVIEW
FULL TEXT
FULL-TEXT PDF (123 KB)
CITATION ALERT
CITED BY
RELATED ARTICLES
EXPORT CITATION
EMAIL TO A COLLEAGUE
RIGHTS/PERMISSIONS
NEED REPRINTS?
BOOKMARK ARTICLE
PHOENIX — Six weeks of treatment for acute exacerbation of schizophrenia using the experimental atypical antipsychotic drug asenapine significantly reduced symptoms, compared with placebo therapy, in a randomized, double-blind study of 458 patients.
PII: S0270-6644(08)70694-5
doi:10.1016/S0270-6644(08)70694-5
© 2008 Elsevier Inc. All rights reserved.
Copyright © 2010 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.